Skip to ContentSkip to Navigation
Over ons Faculty of Science and Engineering Our Research GRIP Pharmaceutical Technology and Biopharmacy Output

2004

Requests for reprints can be addressed to:

Wouter Hinrichs

de Boer AH, Hagedoorn P, Gjaltema D, Frijlink HW

Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers

Pharmazie, 59, 692-699, 2004

de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, Frijlink HW

The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler

Pharm Res, 21, 2158-2166, 2004

de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, Frijlink HW

The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler

Pharm Res, 21, 2167-2174, 2004

de Boer AH, Hagedoorn P, Gjaltema D, Le Brun PPH, Frijlink HW

Meer mogelijkheden met ‘(multiple) air classifier’-technology

PW, 139, 36, 1171-1175, 2004

de Boer AH, Hagedoorn P, Le Brun PPH, Frijlink HW

Instructies bij het gebruik van inhalatoren

PW, 139, 36, 1162-1166, 2004

Bouwman AM, Bosma JC, Vonk P, Wesselingh JA, Frijlink HW

Which shape factor(s) best describe granules?

Powder Techn, 146, 66-72, 2004

Bouwman AM, Visser MR, Eissens AC, Wesselingh JA, Frijlink HW

The effect of vessel material on granules produced in a high-shear mixer

Eur J Pharm Sci, 23, 169-179, 2004

Le Brun PPH, de Boer AH, Frijlink HW

Werkingsprincipes en eigenschappen van toedieningsvormen voor inhalatie

PW, 139, 36, 1157-1161, 2004

van Drooge DJ, Hinrichs WLJ, Frijlink HW

Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent

J Pharm Sci, 93, 713-725, 2004

van Drooge DJ, Hinrichs WLJ, Wegman KAM, Visser MR, Eissens AC, Frijlink HW

Solid dispersions based on inulin for the stabilisation and formulation of Δ9-tetrahydrocannabinol

Eur J Pharm Sci, 21, 511-518, 2004

van Drooge DJ, Hinrichs WLJ, Frijlink HW

Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.

J Control Release, 97, 441-452, 2004

Eriksson HJC, Mol R, Somsen GW, Hinrichs WLJ, Frijlink HW, de Jong GJ

Feasibility of nonvolatile buffers in capillary electrophoresis-electrospray ionization-mass spectrometry of proteins

Electrophoresis, 23, 43-49, 2004

Frijlink HW, de Boer AH

Dry powder inhalers for pulmonary delivery

Expert Opin Drug Deliv, 1, 67-86, 2004

 

Frijlink HW, Le Brun PPH, Brouwers JRBJ

Waarom geavanceerd ook zinvol is

PW, 136, 26, 921-926, 2004

Frijlink HW, de Boer AH

Systemische toediening van geneesmiddelen via de long

PW, 139, 36, 1176-1179, 2004

Irngartinger M, Camuglia V, Damm M, Goede J, Frijlink HW

Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing

Eur J Pharm Biopharm, 58, 7-14, 2004

Rigter IM, Schipper HG, Koopmans RP, van Kan HJM, Frijlink HW, Kager PA, Guchelaar HJ

Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with health volunteers

Antimicrob Agents Chemother, 48, 1051-1054, 2004

van der Veen B, van der Voort Maarschalk K, Bolhuis GK, Frijlink HW

Predicting mechanical properties of compacts containing two components

Powder Techn, 139, 156-164, 2004

Westerman EM, Le Brun PPH, Touw DJ, Frijlink HW, Heijerman HGM

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study

J Cystic Fibrosis, 3, 23-28, 2004

Zijlstra GS, Boersma C, Frijlink HW, Postma MJ

Pharmacoeconomic review of recombinant human dNase in the management of cystic fibrosis

Expert Rev Pharmacoeconomics Outcomes Res, 4(1), 49-59, 2004

Zijlstra GS, Hinrichs WLJ, de Boer AH, Frijlink HW

The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation of cetrorelix

Eur J Pharm Sci, 23, 139-149, 2004

Laatst gewijzigd:09 januari 2020 10:20